Equities

Cosmo Bio Co Ltd

3386:TYO

Cosmo Bio Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,116.00
  • Today's Change19.00 / 1.73%
  • Shares traded6.10k
  • 1 Year change+13.99%
  • Beta0.4414
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue9,3409,5539,231
OPERATING EXPENSES
Cost of revenue total6,0906,1125,572
Selling, general and admin. expenses, total2,6562,5422,539
Depreciation/amortization------
Unusual expense(income)(27)29--
Other operating expenses, total2.001.002.00
Total operating expense8,7948,7668,183
Operating income5467871,048
Other, net368.0026
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes6537901,099
Provision for income taxes191238330
Net income after taxes462552769
Minority interest(19)(35)(31)
Net income before extra. Items443517738
Total extraordinary items------
Net income443517738
Inc.avail. to common excl. extra. Items442517737
Inc.avail. to common incl. extra. Items442517737
EPS RECONCILIATION
Basic/primary weighted average shares5.835.815.81
Basic/primary eps excl. extra items7689127
Basic/primary eps incl. extra items7689127
Dilution adjustment------
Diluted weighted average shares5.835.815.81
Diluted eps excl. extra items7689127
Diluted eps incl. extra items7689127
COMMON STOCK DIVIDENDS
DPS - common stock primary issue303636
Gross dividend - common stock174209208
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental000
SUPPLEMENTAL INCOME
Depreciation, supplemental148141166
Total special items(27)29--
NORMALISED INCOME
Normalized income before taxes6268191,099
Effect of special items on income taxes(7.9)8.74--
Income tax excluding impact of special items183247330
Normalized income after tax443572769
Normalized income avail. to common423537737
Basic normalized EPS7393127
Diluted normalized EPS7393127
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.